Acute myeloid leukemia with FLT3 mutation: a therapeutic window for targeted therapy after allogeneic hematopoietic cell transplantation (alloHCT)

Esteve, J; Labopin, M; Brunet, S; Schmid, C; Poire, X; Bazarbachi, A; Rocha, V; Mohty, M; Nagler, A

BONE MARROW TRANSPLANTATION, 2017; 52 ( ): S116